- We will send in 10–14 business days.
/images/books/5446162/9781071621677.jpg)
- Publisher: Humana
- ISBN-10: 107162167X
- ISBN-13: 9781071621677
- Format: 18.3 x 25.4 x 2.2 cm, hardcover
- Language: English
- SAVE -10% with code: EXTRA
Vaccine Technologies for Veterinary Viral Diseases (e-book) (used book) | bookbook.eu
Reviews
Description
1. An overview of veterinary viral diseases and vaccine technologies
Alejandro Brun
2 .Production and purification of candidate subunit vaccines by IC-tagging protein encapsulation
Natalia Barreiro-Piñeiro; Tomás Pose Boirazian; Rebeca Menaya-Varga, and José M. MartÃnez-Costas.
3. Elastin‐like polymers as nanovaccines: protein engineering of self‐assembled, epitope-exposing nanoparticles
Alessandra Girotti, Juan González‐Valdivieso, Irene Alonso‐Sampedro, Sara Escalera-Anzola, Sandra Ramos‐DÃez, and F. Javier Arias
4. Display of heterologous proteins in Bacillus subtilis biofilms for enteric immunization
Ramona Wissmann, Cornel Fraefel, Claudio Aguilar, and Catherine Eichwald
5. Production of influenza H5 vaccine oligomers in plants
Hoang Trong Phan and Udo Conrad
Chapter 6
DNA vaccines in pigs: from immunization to antigen identification.
Francesc Accensi, Laia Bosch-Camós, Paula L. Monteagudo and Fernando RodrÃguez
7. Use of foot-and-mouth disease virus non-coding synthetic RNAs as vaccine adjuvants
Miguel RodrÃguez-Pulido, Miryam Polo, Belén Borrego, and Margarita Sáiz
8. Evaluation of innate lymphoid cells and dendritic cells following viral vector vaccination.
Zheyi Li, Sreeja Roy, and Charani Ranasinghe
9. Generation of replication deficient human adenovirus 5 (Ad5) vectored FMD vaccines.
Gisselle N. Medina, Teresa de los Santos, and Fayna Diaz-San Segundo
10. Recombinant modified vaccinia virus Ankara development to express VP2, NS1, and VP7 proteins of Bluetongue virus
Alejandro MarÃn-López, Sergio Utrilla-Trigo, Luis Jiménez-Cabello, and Javier Ortego.
11. Cloning strategies for the generation of recombinant capripoxvirus through the use of screening and selection markers
Hani Boshra, Mahder Teffera, Jinxing Cao, and Shawn Babiuk
12. Using Rift Valley fever virus as a vector platform for the expression of ruminant disease antigens
Sandra Moreno Belén Borrego and Alejandro Brun
13. Generation and characterization of single-cycle infectious canine Influenza A Virus (sciCIV) and its use as vaccine platform
Aitor Nogales, Kevin Chiem, Michael Breen, Marta L DeDiego, Colin R Parrish, and Luis MartÃnez-Sobrido
14. Reverse genetics for influenza A and B viruses driven by swine polymerase I promoter.
Brittany Seibert, Stivalis Cardenas-Garcia, Daniela Rajao, and Daniel R. Perez
15. Analysis of the cellular immune responses to vaccines
Nicholas Svitek, Evans L. N. Taracha, Rosemary Saya, Elias Awino, Vish Nene, and Lucilla Steinaa
EXTRA 10 % discount with code: EXTRA
The promotion ends in 16d.23:31:51
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: Humana
- ISBN-10: 107162167X
- ISBN-13: 9781071621677
- Format: 18.3 x 25.4 x 2.2 cm, hardcover
- Language: English English
1. An overview of veterinary viral diseases and vaccine technologies
Alejandro Brun
2 .Production and purification of candidate subunit vaccines by IC-tagging protein encapsulation
Natalia Barreiro-Piñeiro; Tomás Pose Boirazian; Rebeca Menaya-Varga, and José M. MartÃnez-Costas.
3. Elastin‐like polymers as nanovaccines: protein engineering of self‐assembled, epitope-exposing nanoparticles
Alessandra Girotti, Juan González‐Valdivieso, Irene Alonso‐Sampedro, Sara Escalera-Anzola, Sandra Ramos‐DÃez, and F. Javier Arias
4. Display of heterologous proteins in Bacillus subtilis biofilms for enteric immunization
Ramona Wissmann, Cornel Fraefel, Claudio Aguilar, and Catherine Eichwald
5. Production of influenza H5 vaccine oligomers in plants
Hoang Trong Phan and Udo Conrad
Chapter 6
DNA vaccines in pigs: from immunization to antigen identification.
Francesc Accensi, Laia Bosch-Camós, Paula L. Monteagudo and Fernando RodrÃguez
7. Use of foot-and-mouth disease virus non-coding synthetic RNAs as vaccine adjuvants
Miguel RodrÃguez-Pulido, Miryam Polo, Belén Borrego, and Margarita Sáiz
8. Evaluation of innate lymphoid cells and dendritic cells following viral vector vaccination.
Zheyi Li, Sreeja Roy, and Charani Ranasinghe
9. Generation of replication deficient human adenovirus 5 (Ad5) vectored FMD vaccines.
Gisselle N. Medina, Teresa de los Santos, and Fayna Diaz-San Segundo
10. Recombinant modified vaccinia virus Ankara development to express VP2, NS1, and VP7 proteins of Bluetongue virus
Alejandro MarÃn-López, Sergio Utrilla-Trigo, Luis Jiménez-Cabello, and Javier Ortego.
11. Cloning strategies for the generation of recombinant capripoxvirus through the use of screening and selection markers
Hani Boshra, Mahder Teffera, Jinxing Cao, and Shawn Babiuk
12. Using Rift Valley fever virus as a vector platform for the expression of ruminant disease antigens
Sandra Moreno Belén Borrego and Alejandro Brun
13. Generation and characterization of single-cycle infectious canine Influenza A Virus (sciCIV) and its use as vaccine platform
Aitor Nogales, Kevin Chiem, Michael Breen, Marta L DeDiego, Colin R Parrish, and Luis MartÃnez-Sobrido
14. Reverse genetics for influenza A and B viruses driven by swine polymerase I promoter.
Brittany Seibert, Stivalis Cardenas-Garcia, Daniela Rajao, and Daniel R. Perez
15. Analysis of the cellular immune responses to vaccines
Nicholas Svitek, Evans L. N. Taracha, Rosemary Saya, Elias Awino, Vish Nene, and Lucilla Steinaa
Reviews